Ahmed Sabt

796 total citations
31 papers, 600 citations indexed

About

Ahmed Sabt is a scholar working on Organic Chemistry, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Ahmed Sabt has authored 31 papers receiving a total of 600 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Organic Chemistry, 13 papers in Molecular Biology and 4 papers in Infectious Diseases. Recurrent topics in Ahmed Sabt's work include Synthesis and biological activity (14 papers), Click Chemistry and Applications (8 papers) and Synthesis and Biological Evaluation (8 papers). Ahmed Sabt is often cited by papers focused on Synthesis and biological activity (14 papers), Click Chemistry and Applications (8 papers) and Synthesis and Biological Evaluation (8 papers). Ahmed Sabt collaborates with scholars based in Egypt, Saudi Arabia and Poland. Ahmed Sabt's co-authors include Wagdy M. Eldehna, Tarfah Al‐Warhi, Eslam B. Elkaeed, Omaima M. Abdelhafez, Laila A. Rashed, Hassan M. F. Madkour, Mohamed A. Abdelrahman, Radwan El‐Haggar, Rasha Z. Batran and Mohamed Abdelraof and has published in prestigious journals such as PLoS ONE, Molecules and RSC Advances.

In The Last Decade

Ahmed Sabt

30 papers receiving 592 citations

Peers

Countries citing papers authored by Ahmed Sabt

Since Specialization

Citations

This map shows the geographic impact of Ahmed Sabt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ahmed Sabt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ahmed Sabt more than expected).

Fields of papers citing papers by Ahmed Sabt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ahmed Sabt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ahmed Sabt. The network helps show where Ahmed Sabt may publish in the future.

Co-authorship network of co-authors of Ahmed Sabt

This figure shows the co-authorship network connecting the top 25 collaborators of Ahmed Sabt. A scholar is included among the top collaborators of Ahmed Sabt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ahmed Sabt. Ahmed Sabt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Synthesis and mechanistic insights of Coumarinyl-Indolinone hybrids as potent inhibitors of Leishmania major 2025 ·European Journal of Medicinal Chemistry ·Rasha Z. Batran, (unknown), (unknown), Ninh The Son, (unknown), (unknown), (unknown), Yusuke Kasai, Hiroshi Imagawa, Mohammad M. Al‐Sanea, Tamer M. Ibrahim, Abdelsamed I. Elshamy, Adnan A. Bekhit, Wagdy M. Eldehna, Ahmed Sabt	3
2	Discovery of N′-(1-(coumarin-3-yl)ethylidene)benzenesulfonohydrazide as a novel wound healing enhancer: synthesis, biological assessment, and molecular modeling 2025 ·Frontiers in Chemistry ·Eman F. Khaleel, (unknown), Abdel‐Razik H. Abdel‐Razik, (unknown), Ninh The Son, (unknown), (unknown), Mohamed A. Abdelrahman, Abdelsamed I. Elshamy, Jarosław Dziadek, Ahmed Sabt, Wagdy M. Eldehna	1
3	Exploring antitubercular activity of new coumarin derivatives targeting enoyl acyl carrier protein reductase (InhA): Synthesis, biological evaluation and computational studies 2025 ·Journal of Molecular Structure ·(unknown), Małgorzata Korycka‐Machała, Moataz A. Shaldam, (unknown), (unknown), Bożena Dziadek, (unknown), (unknown), Xinsheng Lei, Abdelsamed I. Elshamy, Jarosław Dziadek, Ahmed Sabt	4
4	An exploration of potent antileishmanial agents derived from quinoline–thiazole and thiadiazole hybrids, targeting DHFR-TS and PTR1: design, synthesis, and computational analyses 2025 ·RSC Medicinal Chemistry ·Huda R. M. Rashdan, Adnan A. Bekhit, (unknown), Kikuko Amagase, Abdelsamed I. Elshamy, (unknown), M.A. Abdo, Tamer M. Ibrahim, Urban Bren, Wagdy M. Eldehna, Ahmed Sabt	0
5	Design, synthesis, and biological assessment of a novel series of coumarin-tethered thiazole derivatives as potential antibacterial agents 2025 ·Frontiers in Chemistry ·(unknown), Hanaa Farag, Mohamed Abdelraof, Abdulrahman M. Saleh, (unknown), Jarosław Dziadek, (unknown), Ahmed Sabt	1
6	New coumarin linked thiazole derivatives as antimycobacterial agents: Design, synthesis, enoyl acyl carrier protein reductase (InhA) inhibition and molecular modeling 2024 ·Bioorganic Chemistry ·Asmaa F. Kassem, Ahmed Sabt, Małgorzata Korycka‐Machała, Moataz A. Shaldam, (unknown), Bożena Dziadek, (unknown), Jarosław Dziadek, Rasha Z. Batran	6
7	Recent studies on protein kinase signaling inhibitors based on thiazoles: review to date 2024 ·RSC Advances ·(unknown), (unknown), Asmaa F. Kassem, Ahmed Sabt	8
8	Discovery of new quinoline derivatives bearing 1-aryl-1,2,3-triazole motif as influenza H1N1 virus neuraminidase inhibitors 2024 ·Bioorganic Chemistry ·Ahmed Sabt, Eman F. Khaleel, Moataz A. Shaldam, (unknown), Rehab Mustafa Badi, Abdou Kamal Allayeh, Wagdy M. Eldehna, Jarosław Dziadek	12
9	Identification of Coumarin-Chalcone and Coumarin-Pyrazoline Derivatives as Novel Anti-Toxoplasma gondii Agents 2024 ·Drug Design Development and Therapy ·(unknown), (unknown), (unknown), (unknown), Urban Bren, Justyna Gatkowska, Jarosław Dziadek, Wagdy M. Eldehna, Ahmed Sabt	1
10	Benzenesulfonohydrazide-tethered non-fused and fused heterocycles as potential anti-mycobacterial agents targeting enoyl acyl carrier protein reductase (InhA) with antibiofilm activity 2024 ·RSC Advances ·Tarfah Al‐Warhi, Ahmed Sabt, Małgorzata Korycka‐Machała, Asmaa F. Kassem, Moataz A. Shaldam, (unknown), (unknown), Bożena Dziadek, (unknown), Wagdy M. Eldehna, Jarosław Dziadek	5
11	Identification of 2-(N-aryl-1,2,3-triazol-4-yl) quinoline derivatives as antitubercular agents endowed with InhA inhibitory activity 2024 ·Frontiers in Chemistry ·Ahmed Sabt, Maha‐Hamadien Abdulla, (unknown), Jakub Pawełczyk, Hayam A. Abd El Salam, Ninh The Son, (unknown), (unknown), (unknown), (unknown), Bożena Dziadek, Jarosław Dziadek, Wagdy M. Eldehna	13
12	An overview of recent advancements in small molecules suppression of oncogenic signaling of K-RAS: an updated review 2024 ·Molecular Diversity ·Ahmed Sabt, Haytham O. Tawfik, Eman F. Khaleel, Rehab Mustafa Badi, (unknown), Eslam B. Elkaeed, Wagdy M. Eldehna	4
13	Novel coumarin-6-sulfonamide-chalcone hybrids as glutathione transferase P1-1 inhibitors 2024 ·PLoS ONE ·Ahmed Sabt, (unknown), (unknown), (unknown), (unknown), (unknown), Eslam B. Elkaeed, (unknown), Nikolaos Angelis, Ourania Tsitsilonis, Anastassios C. Papageorgiou, Urban Bren, Nikolaos E. Labrou	5
14	New pyrazolylindolin-2-one based coumarin derivatives as anti-melanoma agents: design, synthesis, dual BRAF^V600E/VEGFR-2 inhibition, and computational studies 2024 ·RSC Advances ·Ahmed Sabt, Mohammed A. Khedr, Wagdy M. Eldehna, Abdelsamed I. Elshamy, Mohamed F. Abdelhameed, Rasha M. Allam, Rasha Z. Batran	15
15	Identification of new anti-mycobacterial agents based on quinoline-isatin hybrids targeting enoyl acyl carrier protein reductase (InhA) 2024 ·Bioorganic Chemistry ·Eman F. Khaleel, Ahmed Sabt, Małgorzata Korycka‐Machała, Rehab Mustafa Badi, Ninh The Son, (unknown), (unknown), (unknown), Eslam B. Elkaeed, Bożena Dziadek, Wagdy M. Eldehna, Jarosław Dziadek	14
16	An updated review of fatty acid residue-tethered heterocyclic compounds: synthetic strategies and biological significance 2023 ·RSC Advances ·Taghreed A. Majrashi, Ahmed Sabt, Hayam A. Abd El Salam, Ghada H. Al-Ansary, (unknown), Wagdy M. Eldehna	7
17	Modulating leishmanial pteridine metabolism machinery via some new coumarin-1,2,3-triazoles: Design, synthesis and computational studies 2023 ·European Journal of Medicinal Chemistry ·(unknown), Ahmed Sabt, (unknown), Mikko Ora, Alaa El‐Din A. Bekhit, Kikuko Amagase, Adnan A. Bekhit, Ahmed S.F. Belal, Perihan A. Elzahhar	19
18	Antibacterial Activity of Quinoline‐Based Derivatives against Methicillin‐Resistant Staphylococcus aureus and Pseudomonas aeruginosa: Design, Synthesis, DFT and Molecular Dynamic Simulations 2023 ·Chemistry & Biodiversity ·Ahmed Sabt, Mohamed Abdelraof, (unknown), (unknown)	10
19	New antileishmanial quinoline linked isatin derivatives targeting DHFR-TS and PTR1: Design, synthesis, and molecular modeling studies 2022 ·European Journal of Medicinal Chemistry ·Ahmed Sabt, Wagdy M. Eldehna, Tamer M. Ibrahim, Adnan A. Bekhit, Rasha Z. Batran	27
20	Recent advancements of coumarin-based anticancer agents: An up-to-date review 2020 ·Bioorganic Chemistry ·Tarfah Al‐Warhi, Ahmed Sabt, Eslam B. Elkaeed, Wagdy M. Eldehna	166

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact